The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Swine Influenza Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The global Swine Influenza Vaccines market size is expected to reach US$ 167.4 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Swine Influenza Vaccines in various end use industries. The expanding demands from the Commodity Pig and Breeding Pig, are propelling Swine Influenza Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Swine Influenza Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Swine Influenza Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Swine Influenza Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Swine Influenza Vaccines covered in this report include Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Boehringer Ingelheim, Ceva and Ringpu Biology, etc.
The global Swine Influenza Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Global Swine Influenza Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Swine Influenza Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Swine Influenza Vaccines market, by Application
Commodity Pig
Breeding Pig
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
The global Swine Influenza Vaccines market size is expected to reach US$ 167.4 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Swine Influenza Vaccines in various end use industries. The expanding demands from the Commodity Pig and Breeding Pig, are propelling Swine Influenza Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Swine Influenza Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Swine Influenza Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Swine Influenza Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Swine Influenza Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Swine Influenza Vaccines covered in this report include Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Boehringer Ingelheim, Ceva and Ringpu Biology, etc.
The global Swine Influenza Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Global Swine Influenza Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Swine Influenza Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Swine Influenza Vaccines market, by Application
Commodity Pig
Breeding Pig
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Swine Influenza Vaccines Market Overview
1.1 Swine Influenza Vaccines Product Overview
1.2 Swine Influenza Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Swine Influenza Vaccines Market Size by Type
1.3.1 Global Swine Influenza Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Swine Influenza Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Swine Influenza Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Swine Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Swine Influenza Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Type (2018-2023)
2 Global Swine Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Swine Influenza Vaccines Sales (2018-2023)
2.2 Global Top Players by Swine Influenza Vaccines Revenue (2018-2023)
2.3 Global Top Players by Swine Influenza Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Swine Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Swine Influenza Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Influenza Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Influenza Vaccines Market
2.8 Key Manufacturers Swine Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Influenza Vaccines Status and Outlook by Region
3.1 Global Swine Influenza Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Swine Influenza Vaccines Historic Market Size by Region
3.2.1 Global Swine Influenza Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Swine Influenza Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Swine Influenza Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Swine Influenza Vaccines Forecasted Market Size by Region
3.3.1 Global Swine Influenza Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Swine Influenza Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Swine Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Swine Influenza Vaccines by Application
4.1 Swine Influenza Vaccines Market Segment by Application
4.1.1 Commodity Pig
4.1.2 Breeding Pig
4.2 Global Swine Influenza Vaccines Market Size by Application
4.2.1 Global Swine Influenza Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Swine Influenza Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Swine Influenza Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Swine Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Swine Influenza Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Application (2018-2023)
5 North America Swine Influenza Vaccines by Country
5.1 North America Swine Influenza Vaccines Historic Market Size by Country
5.1.1 North America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Swine Influenza Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Swine Influenza Vaccines Sales in Value by Country (2018-2023)
5.2 North America Swine Influenza Vaccines Forecasted Market Size by Country
5.2.1 North America Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Swine Influenza Vaccines Sales in Value by Country (2024-2029)
6 Europe Swine Influenza Vaccines by Country
6.1 Europe Swine Influenza Vaccines Historic Market Size by Country
6.1.1 Europe Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Swine Influenza Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Swine Influenza Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Swine Influenza Vaccines Forecasted Market Size by Country
6.2.1 Europe Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Swine Influenza Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Swine Influenza Vaccines by Region
7.1 Asia-Pacific Swine Influenza Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Swine Influenza Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Swine Influenza Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Swine Influenza Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Influenza Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Swine Influenza Vaccines Sales in Value by Region (2024-2029)
8 Latin America Swine Influenza Vaccines by Country
8.1 Latin America Swine Influenza Vaccines Historic Market Size by Country
8.1.1 Latin America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Swine Influenza Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Swine Influenza Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Swine Influenza Vaccines Forecasted Market Size by Country
8.2.1 Latin America Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Swine Influenza Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Swine Influenza Vaccines by Country
9.1 Middle East and Africa Swine Influenza Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Swine Influenza Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Swine Influenza Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Swine Influenza Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Swine Influenza Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chengdu TECBOND
10.1.1 Chengdu TECBOND Company Information
10.1.2 Chengdu TECBOND Introduction and Business Overview
10.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Chengdu TECBOND Swine Influenza Vaccines Products Offered
10.1.5 Chengdu TECBOND Recent Development
10.2 Green Cross Veterinary
10.2.1 Green Cross Veterinary Company Information
10.2.2 Green Cross Veterinary Introduction and Business Overview
10.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Green Cross Veterinary Swine Influenza Vaccines Products Offered
10.2.5 Green Cross Veterinary Recent Development
10.3 Hipra
10.3.1 Hipra Company Information
10.3.2 Hipra Introduction and Business Overview
10.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hipra Swine Influenza Vaccines Products Offered
10.3.5 Hipra Recent Development
10.4 MSD Animal Health (Merck)
10.4.1 MSD Animal Health (Merck) Company Information
10.4.2 MSD Animal Health (Merck) Introduction and Business Overview
10.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Products Offered
10.4.5 MSD Animal Health (Merck) Recent Development
10.5 Zoetis
10.5.1 Zoetis Company Information
10.5.2 Zoetis Introduction and Business Overview
10.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Zoetis Swine Influenza Vaccines Products Offered
10.5.5 Zoetis Recent Development
10.6 CAHIC
10.6.1 CAHIC Company Information
10.6.2 CAHIC Introduction and Business Overview
10.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CAHIC Swine Influenza Vaccines Products Offered
10.6.5 CAHIC Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Information
10.7.2 Boehringer Ingelheim Introduction and Business Overview
10.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Boehringer Ingelheim Swine Influenza Vaccines Products Offered
10.7.5 Boehringer Ingelheim Recent Development
10.8 Ceva
10.8.1 Ceva Company Information
10.8.2 Ceva Introduction and Business Overview
10.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ceva Swine Influenza Vaccines Products Offered
10.8.5 Ceva Recent Development
10.9 Ringpu Biology
10.9.1 Ringpu Biology Company Information
10.9.2 Ringpu Biology Introduction and Business Overview
10.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Ringpu Biology Swine Influenza Vaccines Products Offered
10.9.5 Ringpu Biology Recent Development
10.10 DHN
10.10.1 DHN Company Information
10.10.2 DHN Introduction and Business Overview
10.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 DHN Swine Influenza Vaccines Products Offered
10.10.5 DHN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Influenza Vaccines Industrial Chain Analysis
11.4 Swine Influenza Vaccines Market Dynamics
11.4.1 Swine Influenza Vaccines Industry Trends
11.4.2 Swine Influenza Vaccines Market Drivers
11.4.3 Swine Influenza Vaccines Market Challenges
11.4.4 Swine Influenza Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Influenza Vaccines Distributors
12.3 Swine Influenza Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
